Related Experiment Video
Updated: Apr 3, 2026

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.7K
Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates
Kevin He1, Yanming Li1, Ji Zhu2
1Department of Biostatistics and.
Bioinformatics (Oxford, England)
|September 19, 2015
Summary
This study introduces a new statistical method for genetics studies using boosting and stability selection to identify important genetic factors for patient survival. The method effectively reduces false discoveries, improving accuracy in high-dimensional data analysis.
Area of Science:
- Genetics and Bioinformatics
- Statistical Genomics
- Computational Biology
Background:
- High-dimensional data in genetics studies necessitates advanced statistical methods.
- Variable selection for censored outcomes and controlling false discoveries are key challenges.
- Existing methods may struggle with the complexity of modern genetic datasets.
Purpose of the Study:
- To develop a computationally feasible method for high-dimensional variable selection in genetics.
- To control false discoveries using stability selection in the presence of many predictors.
- To improve the utilization of rich genetic information for survival analysis.
Main Methods:
- Developed a novel method combining boosting and stability selection.
- Modified component-wise gradient boosting for enhanced computational feasibility.
- Incorporated random permutation within stability selection to control false discoveries.
Main Results:
- The proposed method demonstrated fewer false discoveries compared to univariate and Lasso approaches.
- Applied to cutaneous melanoma (CM) patients, analyzing 2339 single-nucleotide polymorphisms (SNPs).
- Identified associations between BRCA2 and Fanconi anemia (FA) pathway SNPs with patient survival.
Conclusions:
- The new method offers improved accuracy for variable selection in high-dimensional genetic studies.
- Stability selection effectively controls false discoveries, enhancing reliability.
- The findings provide insights into genetic factors influencing cutaneous melanoma patient survival.
Related Concept Videos
Assumptions of Survival Analysis
488
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
488
Truncation in Survival Analysis
717
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
717
Comparing the Survival Analysis of Two or More Groups
711
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
711
Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Survival Tree
497
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
497
Introduction To Survival Analysis
968
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
968

